Ascendis Pharma A/S Receives Positive CHMP Opinion for TransCon™ hGH for Patients with Pediatric Growth Hormone Deficiency

NEXT STORY
NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates
PREV STORY
PMV Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA Approves Radius Health’s TYMLOS™ (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture

TYMLOS is the first new anabolic (bone building) agent for postmenopausal women with osteoporosis ...

author_avatar
NASDAQ Market News

Silicon Valley TMS Now Offering Cutting Edge Mental Health Technology for Obsessive-Compulsive Disorder (OCD) in Northern California

author_avatar
NASDAQ Market News

Rexahn Announces 1-for-10 Reverse Stock Split

ROCKVILLE, Md., April 13, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), a clinical ...

author_avatar
NASDAQ Market News